Pyrimethamine NDC 59651-590

NDC codes

FDA NDC Directory

Product NDC (as listed)59651-590Labeler and product segments. Claims need a package NDC.

Product NDC at billing width59651-0590Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
59651-590-01	59651059001	100 TABLET in 1 BOTTLE (59651-590-01)Marketed from Oct 25, 2022
59651-590-30	59651059030	30 TABLET in 1 BOTTLE (59651-590-30)Marketed from Oct 25, 2022

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Pyrimethamine
Generic name (nonproprietary): pyrimethamine
Active ingredients: Pyrimethamine — 25 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Aurobindo Pharma Limited
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 216983
Marketing start: Oct 25, 2022
Listing expires: Dec 31, 2026
Other FDA classes: Dihydrofolate Reductase Inhibitors (Mechanism)
Identifiers: Product ID 59651-590_3214e53b-6abb-4a20-b849-0558e79dac05SPL ID 3214e53b-6abb-4a20-b849-0558e79dac05SPL set ID 7aca002e-a538-4715-9121-a17bdb7f200cRxCUI 198182UNII Z3614QOX8WUPC 0359651590300
Pharmacologic class: Dihydrofolate Reductase Inhibitor Antimalarial

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N459651059001 followed by a unit qualifier and the quantity

Package 59651-0590-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 19, 2024.

Indications (excerpt from the label)

INDICATIONS AND USAGE Treatment of Toxoplasmosis: Pyrimethamine tablets are indicated for the treatment of toxoplasmosis when used conjointly with a sulfonamide, since synergism exists with this combination.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)